+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Opioid Rescue Products Market 2024-2028

  • PDF Icon

    Report

  • 200 Pages
  • November 2024
  • Region: Global
  • TechNavio
  • ID: 6037072
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The opioid rescue products market is forecasted to grow by USD 1.68 billion during 2023-2028, accelerating at a CAGR of 11.6% during the forecast period. The report on the opioid rescue products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing rates of opioid overdoses, government initiatives to address opioid crisis, and enhanced awareness and educational efforts.

The opioid rescue products market is segmented as below:

By Distribution Channel

  • Offline
  • Online

By Product Type

  • Naloxone
  • Naltrexone
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the approval of new drugs as one of the prime reasons driving the opioid rescue products market growth during the next few years. Also, formation of partnerships and agreements and emphasis on over-the-counter availability will lead to sizable demand in the market.

The report on the opioid rescue products market covers the following areas:

  • Opioid Rescue Products Market sizing
  • Opioid Rescue Products Market forecast
  • Opioid Rescue Products Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading opioid rescue products market vendors that include Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Catalent Inc., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals Plc, Kyowa Kirin Co. Ltd., Mallinckrodt Plc, Novartis AG, Orexo AB, Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the opioid rescue products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Product Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value Chain Analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2023
4.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
5.1 Global Opioid Rescue Products Market 2018 - 2022
Historic Market Size - Data Table on Global Opioid Rescue Products Market 2018 - 2022 ($ million)
5.2 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
5.3 Product Type segment analysis 2018 - 2022
Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
5.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
5.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on the Global Opioid Rescue Products Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
7.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Distribution Channel
8.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
8.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
8.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
8.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
8.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Product Type
9.1 Market segments
Chart on Product Type - Market share 2023-2028 (%)
Data Table on Product Type - Market share 2023-2028 (%)
9.2 Comparison by Product Type
Chart on Comparison by Product Type
Data Table on Comparison by Product Type
9.3 Naloxone - Market size and forecast 2023-2028
Chart on Naloxone - Market size and forecast 2023-2028 ($ million)
Data Table on Naloxone - Market size and forecast 2023-2028 ($ million)
Chart on Naloxone - Year-over-year growth 2023-2028 (%)
Data Table on Naloxone - Year-over-year growth 2023-2028 (%)
9.4 Naltrexone - Market size and forecast 2023-2028
Chart on Naltrexone - Market size and forecast 2023-2028 ($ million)
Data Table on Naltrexone - Market size and forecast 2023-2028 ($ million)
Chart on Naltrexone - Year-over-year growth 2023-2028 (%)
Data Table on Naltrexone - Year-over-year growth 2023-2028 (%)
9.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
9.6 Market opportunity by Product Type
Market opportunity by Product Type ($ million)
Data Table on Market opportunity by Product Type ($ million)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
11.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
11.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
11.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
11.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
11.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
11.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
11.10 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
11.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
11.12 Spain - Market size and forecast 2023-2028
Chart on Spain - Market size and forecast 2023-2028 ($ million)
Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Chart on Spain - Year-over-year growth 2023-2028 (%)
Data Table on Spain - Year-over-year growth 2023-2028 (%)
11.13 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
11.14 South Korea - Market size and forecast 2023-2028
Chart on South Korea - Market size and forecast 2023-2028 ($ million)
Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
Chart on South Korea - Year-over-year growth 2023-2028 (%)
Data Table on South Korea - Year-over-year growth 2023-2028 (%)
11.15 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
11.16 Brazil - Market size and forecast 2023-2028
Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Chart on Brazil - Year-over-year growth 2023-2028 (%)
Data Table on Brazil - Year-over-year growth 2023-2028 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Alkermes Public Ltd. Co.
Alkermes Public Ltd. Co. - Overview
Alkermes Public Ltd. Co. - Product / Service
Alkermes Public Ltd. Co. - Key offerings
SWOT
14.5 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
SWOT
14.6 Emergent BioSolutions Inc.
Emergent BioSolutions Inc. - Overview
Emergent BioSolutions Inc. - Product / Service
Emergent BioSolutions Inc. - Key offerings
SWOT
14.7 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
14.8 Fresenius Kabi AG
Fresenius Kabi AG - Overview
Fresenius Kabi AG - Product / Service
Fresenius Kabi AG - Key offerings
SWOT
14.9 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
SWOT
14.10 Kyowa Kirin Co. Ltd.
Kyowa Kirin Co. Ltd. - Overview
Kyowa Kirin Co. Ltd. - Product / Service
Kyowa Kirin Co. Ltd. - Key offerings
SWOT
14.11 Mallinckrodt Plc
Mallinckrodt Plc - Overview
Mallinckrodt Plc - Business segments
Mallinckrodt Plc - Key news
Mallinckrodt Plc - Key offerings
Mallinckrodt Plc - Segment focus
SWOT
14.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
14.13 Orexo AB
Orexo AB - Overview
Orexo AB - Product / Service
Orexo AB - Key offerings
SWOT
14.14 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
14.15 Purdue Pharma LP
Purdue Pharma LP - Overview
Purdue Pharma LP - Product / Service
Purdue Pharma LP - Key offerings
SWOT
14.16 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
14.17 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
14.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2023 and 2028
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value Chain Analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 21: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 22: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 24: Historic Market Size - Data Table on Global Opioid Rescue Products Market 2018 - 2022 ($ million)
Exhibits 25: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits 26: Historic Market Size - Product Type Segment 2018 - 2022 ($ million)
Exhibits 27: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 28: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 29: Five forces analysis - Comparison between 2023 and 2028
Exhibits 30: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 32: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 33: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 34: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 35: Chart on Market condition - Five forces 2023 and 2028
Exhibits 36: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 37: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 38: Chart on Comparison by Distribution Channel
Exhibits 39: Data Table on Comparison by Distribution Channel
Exhibits 40: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by Distribution Channel ($ million)
Exhibits 49: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 50: Chart on Product Type - Market share 2023-2028 (%)
Exhibits 51: Data Table on Product Type - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Product Type
Exhibits 53: Data Table on Comparison by Product Type
Exhibits 54: Chart on Naloxone - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Naloxone - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Naloxone - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Naloxone - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Naltrexone - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Naltrexone - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Naltrexone - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Naltrexone - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Product Type ($ million)
Exhibits 67: Data Table on Market opportunity by Product Type ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 109: Chart on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 110: Data Table on Spain - Market size and forecast 2023-2028 ($ million)
Exhibits 111: Chart on Spain - Year-over-year growth 2023-2028 (%)
Exhibits 112: Data Table on Spain - Year-over-year growth 2023-2028 (%)
Exhibits 113: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 114: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 115: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 116: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 117: Chart on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits 118: Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
Exhibits 119: Chart on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits 120: Data Table on South Korea - Year-over-year growth 2023-2028 (%)
Exhibits 121: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits 122: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits 123: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 124: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 125: Chart on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits 126: Data Table on Brazil - Market size and forecast 2023-2028 ($ million)
Exhibits 127: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 128: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 129: Market opportunity By Geographical Landscape ($ million)
Exhibits 130: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 131: Impact of drivers and challenges in 2023 and 2028
Exhibits 132: Overview on criticality of inputs and factors of differentiation
Exhibits 133: Overview on factors of disruption
Exhibits 134: Impact of key risks on business
Exhibits 135: Companies covered
Exhibits 136: Company ranking index
Exhibits 137: Matrix on companies position and classification
Exhibits 138: Alkermes Public Ltd. Co. - Overview
Exhibits 139: Alkermes Public Ltd. Co. - Product / Service
Exhibits 140: Alkermes Public Ltd. Co. - Key offerings
Exhibits 141: SWOT
Exhibits 142: Amneal Pharmaceuticals Inc. - Overview
Exhibits 143: Amneal Pharmaceuticals Inc. - Business segments
Exhibits 144: Amneal Pharmaceuticals Inc. - Key news
Exhibits 145: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits 146: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits 147: SWOT
Exhibits 148: Emergent BioSolutions Inc. - Overview
Exhibits 149: Emergent BioSolutions Inc. - Product / Service
Exhibits 150: Emergent BioSolutions Inc. - Key offerings
Exhibits 151: SWOT
Exhibits 152: F. Hoffmann La Roche Ltd. - Overview
Exhibits 153: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 154: F. Hoffmann La Roche Ltd. - Key news
Exhibits 155: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 156: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 157: SWOT
Exhibits 158: Fresenius Kabi AG - Overview
Exhibits 159: Fresenius Kabi AG - Product / Service
Exhibits 160: Fresenius Kabi AG - Key offerings
Exhibits 161: SWOT
Exhibits 162: Hikma Pharmaceuticals Plc - Overview
Exhibits 163: Hikma Pharmaceuticals Plc - Business segments
Exhibits 164: Hikma Pharmaceuticals Plc - Key news
Exhibits 165: Hikma Pharmaceuticals Plc - Key offerings
Exhibits 166: Hikma Pharmaceuticals Plc - Segment focus
Exhibits 167: SWOT
Exhibits 168: Kyowa Kirin Co. Ltd. - Overview
Exhibits 169: Kyowa Kirin Co. Ltd. - Product / Service
Exhibits 170: Kyowa Kirin Co. Ltd. - Key offerings
Exhibits 171: SWOT
Exhibits 172: Mallinckrodt Plc - Overview
Exhibits 173: Mallinckrodt Plc - Business segments
Exhibits 174: Mallinckrodt Plc - Key news
Exhibits 175: Mallinckrodt Plc - Key offerings
Exhibits 176: Mallinckrodt Plc - Segment focus
Exhibits 177: SWOT
Exhibits 178: Novartis AG - Overview
Exhibits 179: Novartis AG - Business segments
Exhibits 180: Novartis AG - Key news
Exhibits 181: Novartis AG - Key offerings
Exhibits 182: Novartis AG - Segment focus
Exhibits 183: SWOT
Exhibits 184: Orexo AB - Overview
Exhibits 185: Orexo AB - Product / Service
Exhibits 186: Orexo AB - Key offerings
Exhibits 187: SWOT
Exhibits 188: Pfizer Inc. - Overview
Exhibits 189: Pfizer Inc. - Product / Service
Exhibits 190: Pfizer Inc. - Key news
Exhibits 191: Pfizer Inc. - Key offerings
Exhibits 192: SWOT
Exhibits 193: Purdue Pharma LP - Overview
Exhibits 194: Purdue Pharma LP - Product / Service
Exhibits 195: Purdue Pharma LP - Key offerings
Exhibits 196: SWOT
Exhibits 197: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 198: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 199: Sun Pharmaceutical Industries Ltd. - Key news
Exhibits 200: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 201: SWOT
Exhibits 202: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 203: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 204: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 205: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 206: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 207: SWOT
Exhibits 208: Viatris Inc. - Overview
Exhibits 209: Viatris Inc. - Business segments
Exhibits 210: Viatris Inc. - Key news
Exhibits 211: Viatris Inc. - Key offerings
Exhibits 212: Viatris Inc. - Segment focus
Exhibits 213: SWOT
Exhibits 214: Inclusions checklist
Exhibits 215: Exclusions checklist
Exhibits 216: Currency conversion rates for US$
Exhibits 217: Research methodology
Exhibits 218: Information sources
Exhibits 219: Data validation
Exhibits 220: Validation techniques employed for market sizing
Exhibits 221: Data synthesis
Exhibits 222: 360 degree market analysis
Exhibits 223: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global opioid rescue products market: Alkermes Public Ltd. Co., Amneal Pharmaceuticals Inc., Catalent Inc., Emergent BioSolutions Inc., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, Hikma Pharmaceuticals Plc, Kyowa Kirin Co. Ltd., Mallinckrodt Plc, Novartis AG, Orexo AB, Pfizer Inc., Purdue Pharma LP, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is approval of new drugs."

According to the report, one of the major drivers for this market is the increasing rates of opioid overdoses.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alkermes Public Ltd. Co.
  • Amneal Pharmaceuticals Inc.
  • Catalent Inc.
  • Emergent BioSolutions Inc.
  • F. Hoffmann La Roche Ltd.
  • Fresenius Kabi AG
  • Hikma Pharmaceuticals Plc
  • Kyowa Kirin Co. Ltd.
  • Mallinckrodt Plc
  • Novartis AG
  • Orexo AB
  • Pfizer Inc.
  • Purdue Pharma LP
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.